By: Killian Meara
AJ Loiacono, co-founder and CEO of Capital RX, discusses how the National Average Drug Acquisition Cost provides accuracy and transparency for stakeholders across the drug supply chain.
Killian Meara is an Associate Editor who specializes in healthcare and medical topics. With a focus on pediatrics and pharmaceuticals, Killian's work has been featured in publications such as Contemporary Pediatrics, Drug Topics, Contagion_Live, AJMC - The American Journal of Managed Care, and Patient Care. Their articles cover a range of subjects including diabetes, respiratory illnesses, vaccination, and public health strategies.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Killian Meara's articles primarily focus on healthcare and pharmaceutical-related topics. The majority of the coverage attributes cite data, indicating a preference for evidence-based information. When reaching out to Killian, provide factually supported insights related to COVID-19, pharmacists' roles in healthcare settings, health impacts such as diabetes and long-term effects of diseases.
Given the emphasis on citing data in his coverage attributes, credible sources with access to relevant research findings or statistical evidence are likely to be well-received by Killian. He appears not to have a specific geographic focus but covers topics from an international perspective.
This information evolves through artificial intelligence and human feedback. Improve this profile .